Oral ibandronate for the treatment of metastatic bone disease in breast cancer: Efficacy and safety results from a randomized, double-blind, placebo-controlled trial (multiple letters) [1]

A. M. Westermann, Debu Tripathy

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)513
Number of pages1
JournalAnnals of Oncology
Volume16
Issue number3
DOIs
StatePublished - Mar 2005
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this